Epiretinal Proliferation in Eyes With F… | Clinical Trial

Key information

Conditions

Macular Disease Eye Diseases Macular Degeneration Retinal Degeneration Retinal Diseases

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Makoto Inoue

Mitaka-shi, Tokyo, 181-8611, Japan

About this study

We evaluated preoperative and postoperative optical coherence tomograpghic images in eyes with full thickness macular hole (FTMH) whether the epiretinal proliferation (EP) was detected and detection of EP was correlated to the visual improvement.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eyes with macular hole

Exclusion criteria

Eyes with retinal detachment, retinal vascular disease, glaucoma, proliferative diabetic retinopathy

Treatment and study plan

Vitrectomy

Procedure

Primary outcomes

Recovery of foveal microstructure

Time frame: 6 months

Secondary outcomes

Visual improvement

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Kyorin University

Other

Registry information

Important dates

Study start: 2013
Primary completion: 2017
Study completion: 2017
First posted: Dec 18, 2017
Registry last updated: Dec 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed